NCT02238236 Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus Status COMPLETED Phase N/A
NCT02238223 Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet Status COMPLETED Phase N/A
NCT02238210 Safety Trial of Atrovent® in Pediatric Patients With Rhinorrhea Associated With a Common Cold or Allergy Status COMPLETED Phase PHASE4
NCT02238197 Postmarketing Surveillance Study of Atrovent® Inhalation Solution in Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A
NCT02238184 Postmarketing Surveillance Study of Anticholinergics - Prescribing Pattern and Therapeutic Long Term Value in Patients Suffering From Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase N/A
NCT02238171 Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A
NCT02238158 Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A
NCT02238145 Postmarketing Surveillance Study of Atrovent® Inhaletten® in Chronic Obstructive Airways Disease Status COMPLETED Phase N/A
NCT02238132 Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways Disease Status COMPLETED Phase N/A
NCT02238119 Efficacy and Safety of Free Combination of Tiotropium + Formoterol Compared to Formoterol and Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE2
NCT02238106 Salmeterol Inhalation Powder Administered as the Xinafoate Salt From Hard Polyethylene Capsules Via the HandiHaler® 2, and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE2
NCT02236741 The Use of Pramipexole and Other Dopamine Agonists and the Risks of Heart Failure and Pneumonia Status COMPLETED Phase N/A
NCT02236728 Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole Status COMPLETED Phase N/A
NCT02236715 Postmarketing Surveillance Study of Atrovent® in Chronic Obstructive Airways Disease Status COMPLETED Phase N/A
NCT02236182 Study to Assess the Safety of Ipratropium Bromide, in Patients With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE2
NCT02236169 Trial to Determine the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to ATROVENT® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE2
NCT02235428 Study to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, in Acute Asthmatic Attacks in Young Children Status TERMINATED Phase PHASE4
NCT02235415 Observation of the Efficacy and Tolerance of Motens® (Lacidipine) in Patients With Essential Hypertension Status COMPLETED Phase N/A
NCT02235402 A Randomised, Parallel-group, Double-blind, Double-dummy Study to Compare the Effects of Lacidipine Versus Bendrofluazide on Markers of Platelet Activation and Haemorheological Factors in Hypertensive Patients Status COMPLETED Phase PHASE4
NCT02235389 A Study of Pre-hospital Treatment of Acute Myocardial Infarction Based on Diagnosis by Interpretation of Remotely Acquired ECG and Thrombolysis With Accelerated Alteplase ( Actilyse®) Status TERMINATED Phase N/A